Chemical Namepatiromer
Dosage FormSuspension (oral; 8.4 gm, 16.8 gm, 25.2 gm)
Drug ClassPotassium binders
SystemBlood, Urinary, Digestive
CompanyRelypsa Inc
Approval Year2015


  • To treat hyperkalemia, a serious condition in which the amount of potassium in the blood is too high.
Last updated on 11/2/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Veltassa (patiromer) Prescribing Information2018Relypsa, Inc., Redwood City, CA
Document TitleYearSource
Patiromer for treating hyperkalaemia.2020NICE